Kailee Rainse / startuprise - Life sciences venture capital firm Sofinnova Partners has closed its latest flagship fund, Sofinnova Capital XI, at €650 million ($750 million), significantly surpassing its original fundraising target. Based in Paris, London, and Milan, Sofinnova Capital…
Back to Top / Monday, November 17, 2025, 1:20 am / permalink 16015 / 4 stories in 3 months
IVFmicro secures £3.5M to boost IVF treatment technology / 2 months
Cellcolabs secures $12M for stem cell therapy scale-up / 4 months
Eli Lilly to acquire Orna Therapeutics in a $2.4B biotech deal / 25 days
Adaptam Therapeutics secures €3M for cancer immunotherapy research / 4 months
Novartis Acquires Avidity Biosciences for $12 Billion Expansion / 4 months
Mycoverse raises €2.4M to commercialize fungal-based crop protection / 3 days
UK biotech Nuclera secures Series C funding for advanced protein research / 7 wks
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.